The Value Creation Clock Is Ticking: Is Your Commercial Engine Ready?
The deal is done, so value creation starts now.
The paperwork is signed and the work begins. Your firm has just closed a strategic investment. Now, the clock starts ticking on value creation – and one big question looms: Is your commercial engine truly ready to deliver?
Are you being kept up at night wondering if your marketing and sales functions are aligned, efficient, and built to scale? Or are there hidden issues that could slow growth, miss targets, and drag down your exit valuation?
The Disconnect: Expectations vs Reality
Private equity investors have high expectations and move fast. Once the deal closes, the pressure’s on to accelerate growth, increase EBITDA, and work towards exit KPIs. That means a strong go-to-market (GTM) motion isn’t optional – it’s essential.
However, when you start looking under the bonnet of these newly invested businesses, the GTM strategy could tell a very different story. CEOs might grasp the importance of effective customer strategies, but many are unsure “what good looks like” or simply where to even begin.
We often see underperforming teams, over investment in marketing without clear returns, lack of connectivity between commercial and business strategy, or simply a misunderstanding of the end customer. These issues quickly create an overwhelming challenge of how a company can hit their ambitious post-investment growth goals.
Stop Guessing: Commercial Health Demands Data, Not Assumptions.
In a high-velocity PE environment, you simply don’t have time for guesswork. Relying on assumptions about a company’s sales and marketing effectiveness can lead to misallocated budgets, prolonged underperformance, and ultimately, a detrimental impact on valuation.
Here are some common failure points:
- Unclear Pipeline Quality: Are you truly evaluating pipeline quality, funnel health, and short-term revenue confidence effectively? Are your MQLs being translated into SQLs effectively and promptly?
- Misaligned Growth Forecasts: Are your growth targets validated against market conditions and resource investment?
- Weak Commercial Story: Is the brand compelling enough to drive demand and support the exit narrative? Do your customers understand you? Do your employees know what you’re trying to achieve?
You need more than just assumptions; you need actionable insights, unwavering confidence, and commercial clarity to unlock hidden value.
Rapid Commercial Diagnostic: Your Secret Weapon
This is where a targeted commercial diagnostic becomes your indispensable tool.
It’s a short, high-impact engagement, typically 5-20 days, designed to rapidly uncover opportunities and de-risk decision-making.
The Growth Partners diagnostic assesses four core pillars:
The diagnostic delivers clear, commercially-driven deliverables, including a board-level summary with actionable strategic insights and tactical priorities, and an actionable roadmap for measurable ROI or revenue growth. This will leave you empowered and enabled to take the next step.
Beyond the Diagnostic: An Informed Approach to Value Creation
Our diagnostic is just the start.
Subsequent phases, such as implementation, upskilling the team, and if needed, ongoing advisory, or fractional leadership, are meticulously tailored to your specific needs, all focused on execution and key deliverables.
At Growth Partners, we connect you with experts in Go-To-Market, Marketing, RevOps, and Product. Our rigorous vetting process ensures only the best join our network – 95% of consultants don’t meet our stringent criteria. This means you gain access to tried and tested, board-level expertise and actionable insights and deliverables.
Unlock Your Portfolio’s Full Commercial Potential
Don’t leave your portfolio’s commercial success to chance. Proactive, data-driven insights are crucial for accelerating growth and maximising valuation.
Want to learn more? Schedule a free consultation.
